For research use only. Not for use in diagnostic procedures.
Regulated and non-regulated bioanalytical studies are an integral part of the Drug Discovery and Development workflow. From ADME and DMPK stages to developing to Phase III, bioanalytical scientists are always tasked with the complicated challenge of developing sensitive, robust, reliable methods to quantify more drug candidates, faster.
SCIEX solutions in quantification of small molecules has enabled hundreds of scientists, and has been related to the launch of several pharmaceutical drugs. The power of the Triple Quad and QTRAP Systems, best-in-class software, and outstanding application support team has ensured that bioanalytical scientists have the ability to make confident decisions to develop better therapeutics, faster.